Aziyo Biologics (AZYO)


From Benzinga Pro
Aziyo Reaffirms FY22 Total Net Sales Guidance $47M-$50M
9 May 22
News, Guidance
Guidance for Full Year 2022 Aziyo is confirming its expectation that total net sales for the full year 2022 will range between $47 to $50 million. Excluding approximately $4.9 million of FiberCel sales in 2021, this
Aziyo Biologics Q1 EPS $(0.60) Beats $(0.62) Estimate, Sales $11.50M Beat $10.78M Estimate
9 May 22
Earnings, News
Aziyo Biologics (NASDAQ:AZYO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.62) by 3.23 percent. This is a 20 percent decrease over losses of $(0.50) per share from the
Earnings Scheduled For May 9, 2022
9 May 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
A Preview Of Aziyo Biologics's Earnings
6 May 22
Aziyo Biologics (NASDAQ:AZYO) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Aziyo Biologics will report an earnings per share (EPS) of $-0.62.
68 Biggest Movers From Yesterday
19 Apr 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core network functions.
12 Health Care Stocks Moving In Monday's Intraday Session
18 Apr 22
Intraday Update, Markets, Movers